Azmi Nabulsi
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | M.D., M.P.H. Former Chief Operating Officer | $219,750 | $2,714,314 |
| 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | M.D., M.P.H. Chief Operating Officer | $569,000 | $1,566,541 |
| 2023 | Phathom Pharmaceuticals, Inc. (PHAT) | M.D., M.P.H. Chief Operating Officer | $552,000 | $2,035,913 |
| 2022 | Phathom Pharmaceuticals, Inc. (PHAT) | M.D., M.P.H. Chief Operating Officer | $525,000 | $2,762,453 |
| 2021 | Phathom Pharmaceuticals, Inc. (PHAT) | M.D., M.P.H. Chief Operating Officer | $491,250 | $4,321,236 |
| 2020 | Phathom Pharmaceuticals, Inc. (PHAT) | M.D., M.P.H. Chief Operating Officer | $445,065 | $2,364,214 |
| 2019 | Phathom Pharmaceuticals, Inc. (PHAT) | M.D., M.P.H. Chief Operating Officer | $388,522 | $531,029 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.